Uno T, Kondo H, Inoue Y, Kawahata Y, Sotomura M, Iuchi K, Tsukamoto G
Pharmaceuticals Research Center, Kanebo Ltd., Osaka, Japan.
J Med Chem. 1990 Oct;33(10):2929-32. doi: 10.1021/jm00172a039.
A series of novel pyridone carboxylic acids having a 4-hydroxypiperazinyl group at the 7-position of norfloxacin and ciprofloxacin were prepared. The in vivo antibacterial efficacies of these compounds were superior to those of corresponding piperazinyl derivatives. From the results of the studies on the pharmacokinetic profile and toxicity, the 4-hydroxypiperazinyl derivatives were confirmed to be pharmacologically superior to corresponding piperazinyl derivatives. Thus, a 4-hydroxypiperazinyl group was revealed to be a beneficial substituent for potential use in future quinolone antibacterials.
制备了一系列在诺氟沙星和环丙沙星7位带有4-羟基哌嗪基的新型吡啶酮羧酸。这些化合物的体内抗菌效力优于相应的哌嗪基衍生物。从药代动力学特征和毒性的研究结果来看,4-羟基哌嗪基衍生物在药理学上被证实优于相应的哌嗪基衍生物。因此,4-羟基哌嗪基被揭示为未来喹诺酮类抗菌药物潜在应用中的一个有益取代基。